Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 410

The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Open access
Garg, Abhishek D., Galluzzi, Lorenzo, Apetoh, Lionel, Baert, Thais, Birge, Raymond B., Bravo-San Pedro, José Manuel, Breckpot, Karine, Brough, David, Chaurio, Ricardo, Cirone, Mara, Coosemans, An, Coulie, Pierre G., De Ruysscher, Dirk, Dini, Luciana, de Witte, Peter, Dudek-Peric, Aleksandra M., Faggioni, Alberto, Fucikova, Jitka, Gaipl, Udo S., Golab, Jakub, Gougeon, Marie-Lise, Hamblin, Michael R., Hemminki, Akseli, Herrmann, Martin, Hodge, James W., Kepp, Oliver, Kroemer, Guido, Krysko, Dmitri V., Land, Walter G., Madeo, Frank, Manfredi, Angelo A., Mattarollo, Stephen R., Maueroder, Christian, Merendino, Nicolò, Multhoff, Gabriele, Pabst, Thomas, Ricci, Jean-Ehrland, Riganti, Chiara, Romano, Erminia, Rufo, Nicole, Smyth, Mark J., Sonnemann, Jürgen, Spisek, Radek, Stagg, John, Vacchelli, Erika, Vandenabeele, Peter, Vandenberk, Lien, Van den Eynde, Benoit J., Van Gool, Stefaan, Velotti, Francesca, Zitvogel, Laurence, Agostinis, Patrizia·2015·Frontiers in Immunology

Abstract

The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by cells succumbing to immunogenic cell death (ICD) favors the establishment of a productive interface with the immune system. This results in the elicitation of tumor-targeting immune responses associated with the elimination of residual, treatment-resistant cancer cells, as well as with the establishment of immunological memory. Although ICD has been characterized with increased precision since its discovery, several questions remain to be addressed. Here, we summarize and tabulate the main molecular, immunological, preclinical, and clinical aspects of ICD, in an attempt to capture the essence of this phenomenon, and identify future challenges for this rapidly expanding field of investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2015.00588

Cites

248 of 248 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 248 references

Research works printed but not linked: 9

  1. Liao, 1974, Comparative immunogenicity of irradiated, neuraminidase treated, and fused cells of a strain-restricted sarcoma, Z Krebsforsch klin Onkol Cancer Res Clin Oncol, 82, 133, 10.1007/BF00284498 · doi:10.1007/bf00284498
  2. Milas, 1976, Nonspecific immunotherapy of malignant tumors, Radiology, 118, 211, 10.1148/118.1.211 · doi:10.1148/118.1.211
  3. Bogden, 1978, Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma, Natl Cancer Inst Monogr, 97
  4. Dickson, 1982, Hyperthermia: the immune response and tumor metastasis, Natl Cancer Inst Monogr, 61, 183
  5. Suit, 1980, Assessment of the response of tumours to radiation: clinical and experimental studies, Br J Cancer Suppl, 4, 1
  6. Richert, 1986, Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure, Cancer Immunol Immunother, 22, 119, 10.1007/BF00199125 · doi:10.1007/bf00199125
  7. Gough, 2004, Induction of cell stress through gene transfer of an engineered heat shock transcription factor enhances tumor immunogenicity, Gene Ther, 11, 1099, 10.1038/sj.gt.3302274 · doi:10.1038/sj.gt.3302274
  8. Bian, 2011, Caspase- and p38-MAPK-dependent induction of apoptosis in A549 lung cancer cells by Newcastle disease virus, Arch Virol, 156, 1335, 10.1007/s00705-011-0987-y · doi:10.1007/s00705-011-0987-y
  9. Tubiana, 1986, Klaas Breur medal lecture 1985. The growth and progression of human tumors: implications for management strategy, Radiother Oncol, 6, 167, 10.1016/S0167-8140(86)80151-7 · doi:10.1016/s0167-8140(86)80151-7

Cited by

See all 410

Metadata

Authors
Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., Coosemans, A., Coulie, P. G., De Ruysscher, D., Dini, L., de Witte, P., Dudek-Peric, A. M., Faggioni, A., Fucikova, J., Gaipl, U. S., Golab, J., Gougeon, M.-L., Hamblin, M. R., Hemminki, A., Herrmann, M., Hodge, J. W., Kepp, O., Kroemer, G., Krysko, D. V., Land, W. G., Madeo, F., Manfredi, A. A., Mattarollo, S. R., Maueroder, C., Merendino, N., Multhoff, G., Pabst, T., Ricci, J.-E., Riganti, C., Romano, E., Rufo, N., Smyth, M. J., Sonnemann, J., Spisek, R., Stagg, J., Vacchelli, E., Vandenabeele, P., Vandenberk, L., Van den Eynde, B. J., Van Gool, S., Velotti, F., Zitvogel, L., & Agostinis, P.
Venue
Frontiers in Immunology
Published
2015-11-20
Volume
6
Pages
588-588
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2173550086
Cited by
410
References
248
FWCI
16.63
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. https://app.cochat.ai/papers/10.3389/fimmu.2015.00588
The paper
Garg, A. D., Galluzzi, L., Apetoh, L., Baert, T., Birge, R. B., Bravo-San Pedro, J. M., Breckpot, K., Brough, D., Chaurio, R., Cirone, M., Coosemans, A., Coulie, P. G., De Ruysscher, D., Dini, L., de Witte, P., Dudek-Peric, A. M., Faggioni, A., Fucikova, J., Gaipl, U. S., . . . Agostinis, P. (2015). Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2015.00588

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.